Arcturus Therapeutics Holdings (ARCT) Net Equity Issued and Repurchased (2020 - 2025)

Arcturus Therapeutics Holdings (ARCT) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $11.7 million in Q4 2025.

• Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $11.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $360.0 million (changed N/A YoY) and the FY2025 annual result came in at $11.7 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased slipped to $11.7 million in Q4 2025, from $161.9 million in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $11.7 million in Q4 2025 to a low of $11.7 million in Q4 2025.